or
forgot password
  • cancer clinical trials in mobile, AL

  • Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    MBCCOP - Gulf Coast
    Mobile, Alabama 36688
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    MBCCOP - Gulf Coast
    Mobile, Alabama 36688
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Breast Cancer, Osteoporosis
    Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Colorectal Cancer, Metastatic Cancer
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    University of South Alabama Cancer Research Institute
    Mobile, Alabama 36604
    Leukemia
    A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE
    Michael Meshad, Oncology Center
    Mobile, Alabama 36608
    Multiple Myeloma
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Lung Cancer
    Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
    U. of S. Alabama Medical Center
    Mobile, Alabama 36604
    Anemia, Sickle Cell
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Pancreatic Cancer
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Esophageal Cancer
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Head and Neck Cancer
    Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Esophageal Cancer
    ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
    University of South Alabama
    Mobile, Alabama 36693
    Pancreatic Cancer, Adenocarcinoma
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Esophageal Cancer
    S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Multiple Myeloma, Plasmacytoma
    ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Breast Cancer
    Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients
    University of South Alabama Medical Center

    Trial Locations
    University of South Alabama Medical Center
    University of South Alabama
    Sickle Cell Disease, Iron Overload, Hemolytic Anemia
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Coastal Clinical Research
    Mobile, Alabama 36608
    Prostate Cancer, Osteoporosis, Fractures
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Southern Cancer Center, Sacred Heart Heath System Medical Oncology Group
    Mobile, Alabama 36608
    Neoplasms, Unknown Primary
    Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
    University of South Alabama
    Mobile, Alabama 36693
    Priapism, Anemia, Sickle Cell
    Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
    University of South Alabama Cancer Research Institute
    Mobile, Alabama 36604
    Chronic Myeloid Leukemia
    PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
    Providence Hospital
    Mobile, Alabama 36608
    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
    Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
    University of South Alabama Mitchell Cancer Institute
    Mobile, Alabama 36604
    Advanced Unresectable Pancreatic Cancer
    A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
    University of South Alabama
    Mobile, Alabama 36693
    Head and Neck Neoplasms, Carcinoma, Squamous Cell
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Mobile Heart Specialists, Pc

    Trial Locations
    Mobile Heart Specialists, Pc
    Clara V. Massey, Md
    Atrial Fibrillation, Atrial Flutter
    Assessment and Tracking of Long-term Alefacept Safety
    Mobile Dermatology
    Mobile, Alabama 36609
    Psoriasis
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of South Alabama Mitchell Cancer Institute
    Mobile, Alabama 36604
    Leukemia
    Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
    University of South Alabama Hospital, Mitchell Cancer Institute
    Mobile, Alabama 36607
    Melanoma
    A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
    Southern Cancer Center
    Mobile, Alabama 36608
    Acute Myeloid Leukemia
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site 146
    Mobile, Alabama 33608
    Hypoactive Sexual Desire Disorder
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    University of South Alabama/Mitchell Cancer Institute
    Mobile, Alabama 36604
    Non-Small Cell Lung Cancer
    Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
    University of South Alabama
    Mobile, Alabama 36693
    Ileostomy, When Applicable, Rectal Cancer, When Applicable, Ulcerative Colitis, FAP, Diverticulitis, Hartmann's Reversal
    ChemoFx® PRO - A Post-Market Data Collection Study
    University of South Alabama
    Mobile, Alabama 36693
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
    Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
    WILMAX Clinical Research
    Mobile, Alabama 36608
    Genital Warts
    BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy
    University of South Alabama
    Mobile, Alabama 36693
    Colon Cancer
    Safety/Efficacy Study of a Drug to Reduce Thrombocytopenia in Patients Receiving Chemotherapy for Ovarian, Fallopian Tube or Peritoneal Cancer
    University of Southern Alabama Mitchell Cancer Institute
    Mobile, Alabama 36604
    Thrombocytopenia, Neutropenia, Lymphopenia, Anemia
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Lymphoma
    Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
    Providence Hospital
    Mobile, Alabama 36608
    Severe Sepsis
    A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma
    Southern Cancer Center
    Mobile, Alabama 36608
    Renal Cell Carcinoma
    Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
    University of South Alabama / Mitchell Cancer Institute SC
    Mobile, Alabama 36688
    Metastatic or Unresectable Cutaneous Melanoma